S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Organon & Co.

OGN XNYS
$13.60 +0.05 (+0.37%) ▲ 15-min delayed
Open
$13.57
High
$13.61
Low
$13.55
Volume
3.33M
Market Cap
$3.56B

About Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 10.0K Website →

Key Financials

Period Revenue Net Income EPS
Q2 2026 $1.56B $108.00M $0.41
Q1 2026 $1.46B $146.00M $0.56
FY 2025 $6.22B $187.00M $0.72
Q3 2025 $1.60B $160.00M $0.61

Related Market News

No specific coverage for OGN yet. Check out our latest market news or earnings calendar.

Get OGN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Organon & Co..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.